CASE STUDY > INTAS

How Intas Turned a First-of-Its-Kind IVF Innovation Into a Hands-On VR Experience

How Intas Turned a First-of-Its-Kind IVF Innovation Into a Hands-On VR Experience

A needle-free injection system is easier to understand when doctors can actually see how it works. So, for ISAR 2026, AutoVRse helped Intas turn a complex medical innovation into an interactive VR experience that clinicians could explore themselves—in just 15 days.

At a glance

At a glance

  • Immersive VR Interactive simulation of a needle-free injection system

  • 15-day development timeline

  • Built for clinicians and specialists at ISAR 2026

  • Immersive VR Interactive simulation of a needle-free injection system

  • 15-day development timeline

  • Built for clinicians and specialists at ISAR 2026

Challenge: Explaining a completely new way to deliver IVF medication

Challenge: Explaining a completely new way to deliver IVF medication

IVF treatment can involve repeated injections across multiple cycles. Intas, in partnership with IntegriMedical, introduced the Needle-Free Injection System (N-FIS™)—a new approach designed to deliver medication without a conventional needle.

Instead, the system uses a high-pressure micro-jet to deliver medication through the skin.

For clinicians encountering the technology for the first time, explaining how that mechanism works—and how the device is used in practice—can be difficult through conventional product videos, brochures or static demonstrations.

Intas needed a way to make the technology clear, practical and easy to understand for doctors attending ISAR 2026.

And they needed it fast.

IVF treatment can involve repeated injections across multiple cycles. Intas, in partnership with IntegriMedical, introduced the Needle-Free Injection System (N-FIS™)—a new approach designed to deliver medication without a conventional needle.

Instead, the system uses a high-pressure micro-jet to deliver medication through the skin.

For clinicians encountering the technology for the first time, explaining how that mechanism works—and how the device is used in practice—can be difficult through conventional product videos, brochures or static demonstrations.

Intas needed a way to make the technology clear, practical and easy to understand for doctors attending ISAR 2026.

And they needed it fast.

Solution: Put clinicians in the driver's seat

AutoVRse created an immersive VR experience that lets clinicians explore the N-FIS™ technology through a step-by-step virtual demonstration.

Rather than simply watching how the device works, users could interact with a virtual patient and experience the application process themselves.

The experience was designed to answer the questions that matter when encountering a new medical device:

  • How does the device work?

  • How is it applied?

  • What happens during the injection?

  • How does a needle-free delivery system differ from conventional injection?

  • What does the process look like from the clinician's perspective?

By turning an abstract mechanism into an interactive experience, VR gave clinicians a way to see, understand and try the technology for themselves.

AutoVRse created an immersive VR experience that lets clinicians explore the N-FIS™ technology through a step-by-step virtual demonstration.

Rather than simply watching how the device works, users could interact with a virtual patient and experience the application process themselves.

The experience was designed to answer the questions that matter when encountering a new medical device:

  • How does the device work?

  • How is it applied?

  • What happens during the injection?

  • How does a needle-free delivery system differ from conventional injection?

  • What does the process look like from the clinician's perspective?

By turning an abstract mechanism into an interactive experience, VR gave clinicians a way to see, understand and try the technology for themselves.

From product launch to hands-on learning—in 15 days

The experience was developed and deployed within a 15-day timeline, ready for Intas's global-stage showcase at ISAR 2026.

That meant taking a complex medical device, understanding its clinical application, translating it into an intuitive virtual experience and getting it exhibition-ready—all within two weeks.

At the event, clinicians from around the world were able to experience the technology themselves, many completing the full experience independently within minutes—even if it was their first time using VR.

The experience was developed and deployed within a 15-day timeline, ready for Intas's global-stage showcase at ISAR 2026.

That meant taking a complex medical device, understanding its clinical application, translating it into an intuitive virtual experience and getting it exhibition-ready—all within two weeks.

At the event, clinicians from around the world were able to experience the technology themselves, many completing the full experience independently within minutes—even if it was their first time using VR.

The result: Innovation clinicians could experience, not just see

The VR experience gave Intas a new way to demonstrate N-FIS™ to healthcare professionals.

Visitors could:

  • Explore the device in an immersive clinical environment

  • See the injection process step by step

  • Interact with a virtual patient

  • Understand the technology without relying solely on brochures or video

  • Complete the experience independently within minutes

Several clinicians reported that using the device on a virtual patient made its working clearer than simply watching a video or viewing product material.

For a first-of-its-kind medical technology, that distinction matters.

Making complex healthcare innovation easier to understand

Intas operates across more than 85 countries, with a focus on making advanced healthcare more accessible through complex generics and biosimilars.

The N-FIS™ represents another kind of innovation: changing how medication can be delivered to patients undergoing demanding IVF and gynaecological treatments.

VR helped bridge the gap between how the technology works and how clinicians understand it.

Instead of asking doctors to imagine a new procedure from a brochure, Intas gave them an opportunity to experience it.

A new model for showcasing medical innovation

The ISAR 2026 experience demonstrates how immersive technology can help healthcare companies communicate complex products more effectively—particularly when the technology itself is difficult to demonstrate in a conventional exhibition environment.

For Intas, this is just the beginning.

With the foundation established, the same approach can be extended to more clinical, therapeutic and medical-device use cases, creating immersive experiences that help healthcare professionals move from awareness to understanding—and, ultimately, adoption.

Let’s talk about

Let’s talk about

Let’s talk about

your training

your training

your training

Talk to our team to learn how to implement VR training at scale

Talk to our team to learn how to implement VR training at scale

Talk to our team to learn how to implement VR training at scale